NCT00865631 - A Limited Food Effect Study of Gabapentin 800 mg Tablets | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

June 30, 1999

Primary Completion Date

June 30, 1999

Study Completion Date

June 30, 1999

Conditions

Healthy

Interventions

DRUG

Gabapentin 800 mg tablets, single dose (1 tablet)

A: Experimental Subjects received Purepac formulated products under fasting conditions

DRUG

NEURONTIN® 400 mg capsules, single dose (2 capsules)

B: Active comparator Subjects received Parke-Davis formulated products under non-fasting conditions

DRUG

Gabapentin 800 mg tablets, single dose (1 tablet)

A: Experimental Subjects received Purepac formulated products under non-fasting conditions

Trial Locations (1)

PRACS Institute, Ltd., Fargo